| Product Code: ETC7820295 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Kiribati Cannabis Pharmaceutical Market Overview |
3.1 Kiribati Country Macro Economic Indicators |
3.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, 2021 & 2031F |
3.3 Kiribati Cannabis Pharmaceutical Market - Industry Life Cycle |
3.4 Kiribati Cannabis Pharmaceutical Market - Porter's Five Forces |
3.5 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By Compound Type, 2021 & 2031F |
3.8 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Kiribati Cannabis Pharmaceutical Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Kiribati Cannabis Pharmaceutical Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing acceptance of cannabis for medicinal purposes |
4.2.2 Increasing research and development activities in the cannabis pharmaceutical sector |
4.2.3 Rising prevalence of chronic diseases that can be treated with cannabis-based products |
4.3 Market Restraints |
4.3.1 Strict regulatory environment surrounding cannabis use in Kiribati |
4.3.2 Limited infrastructure and resources for pharmaceutical manufacturing and distribution |
4.3.3 Cultural stigmas associated with cannabis consumption in Kiribati |
5 Kiribati Cannabis Pharmaceutical Market Trends |
6 Kiribati Cannabis Pharmaceutical Market, By Types |
6.1 Kiribati Cannabis Pharmaceutical Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.4 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Concentrates, 2021- 2031F |
6.1.5 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Edibles, 2021- 2031F |
6.2 Kiribati Cannabis Pharmaceutical Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Epidiolex, 2021- 2031F |
6.2.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Marinol, 2021- 2031F |
6.2.4 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Cesamet, 2021- 2031F |
6.2.5 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Sativex, 2021- 2031F |
6.3 Kiribati Cannabis Pharmaceutical Market, By Compound Type |
6.3.1 Overview and Analysis |
6.3.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Tetrahydrocannabinol (THC), 2021- 2031F |
6.3.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Cannabidiol (CBD), 2021- 2031F |
6.3.4 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Balanced THC & CBD, 2021- 2031F |
6.4 Kiribati Cannabis Pharmaceutical Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Inflammation, 2021- 2031F |
6.4.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Chronic Pain, 2021- 2031F |
6.4.4 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.4.5 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Sleep Disorders, 2021- 2031F |
6.4.6 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Anorexia, 2021- 2031F |
6.4.7 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.5 Kiribati Cannabis Pharmaceutical Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Hospital, 2021- 2031F |
6.6 Kiribati Cannabis Pharmaceutical Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Kiribati Cannabis Pharmaceutical Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Kiribati Cannabis Pharmaceutical Market Import-Export Trade Statistics |
7.1 Kiribati Cannabis Pharmaceutical Market Export to Major Countries |
7.2 Kiribati Cannabis Pharmaceutical Market Imports from Major Countries |
8 Kiribati Cannabis Pharmaceutical Market Key Performance Indicators |
8.1 Number of clinical trials conducted on cannabis-based pharmaceuticals in Kiribati |
8.2 Investment in cannabis pharmaceutical research and development in Kiribati |
8.3 Adoption rate of cannabis pharmaceutical products by healthcare professionals in Kiribati |
8.4 Number of partnerships between local and international pharmaceutical companies for cannabis-based product development |
8.5 Patient satisfaction and reported effectiveness of cannabis pharmaceutical treatments in Kiribati |
9 Kiribati Cannabis Pharmaceutical Market - Opportunity Assessment |
9.1 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By Compound Type, 2021 & 2031F |
9.4 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Kiribati Cannabis Pharmaceutical Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Kiribati Cannabis Pharmaceutical Market - Competitive Landscape |
10.1 Kiribati Cannabis Pharmaceutical Market Revenue Share, By Companies, 2024 |
10.2 Kiribati Cannabis Pharmaceutical Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here